0001127602-12-029015.txt : 20121023 0001127602-12-029015.hdr.sgml : 20121023 20121023184136 ACCESSION NUMBER: 0001127602-12-029015 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20121022 FILED AS OF DATE: 20121023 DATE AS OF CHANGE: 20121023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patton Cynthia M CENTRAL INDEX KEY: 0001560565 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 121157252 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 3 1 form3.xml PRIMARY DOCUMENT X0206 3 2012-10-22 0 0000318154 AMGEN INC AMGN 0001560565 Patton Cynthia M ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 SVP & CCO Common Stock 7554 D Common Stock 48.9635 I 401(k) Plan Nqso (Right to Buy) 50.44 2013-04-28 2016-04-28 Common Stock 900 D Nqso (Right to Buy) 58.43 2013-04-26 2020-04-26 Common Stock 1840 D Nqso (Right to Buy) 54.69 2013-04-25 2021-04-25 Common Stock 5225 D These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 129 RSUs which fully vest on 4/28/2013; 263 RSUs which vest in two installments of 131 and 132 on 4/26/2013 and 4/26/2014, respectively; 3,000 RSUs which vest in three equal annual installments of 1,000 each commencing 10/28/2012; 1,493 RSUs which vest in three installments of 492, 493 and 508 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 11 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. These stock options are exercisable in two equal annual installments of 920 each commencing on 4/26/2013. These stock options are exercisable in two annual installments of 1,724 each on 4/25/2013 and 4/25/2014 and one installment of 1,777 on 4/25/2015. /s/ Cynthia M. Patton 2012-10-22 EX-24 2 doc1.txt POWER OF ATTORNEY (PUBLIC): POA Exhibit 24 Power of Attorney Know all men by these presents, that the undersigned hereby constitutes and appoints each of John C. Ayres, Richard T. Benson and Andrea A. Robinson, signing singly, the undersigneds true and lawful attorney-in-fact to execute for and on behalf of the undersigned Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder, as may be required as a result of the undersigneds position as an officer and/or director of Amgen Inc. (the Company). The undersigned hereby grants to each such attorney-in-fact full power and authority to execute such Forms 3, 4 and 5 as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-facts substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigneds responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigneds holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys- in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 16th day of October, 2012. /s/ Cynthia M. Patton Name: Cynthia M. Patton